StockAnalysis alternatives
StockAnalysis is excellent
for reading financials.
Not for screening them.
StockAnalysis.com is one of the best free tools for browsing a single company's income statement, balance sheet, or earnings history. But it is not a filter-driven screener — you cannot simultaneously apply P/E, ROE, and margin filters across thousands of European and US stocks. These alternatives are built for that workflow.
Updated June 2026 · 5 alternatives reviewed
What a filter-driven screener gives you over StockAnalysis
Apply filters simultaneously
StockAnalysis lets you look up one stock at a time. A screener lets you define criteria — P/E under 15, ROE above 20%, positive free cash flow — and instantly see every stock that qualifies across thousands of instruments.
European coverage
StockAnalysis focuses on US equities. ScreenerHero covers all European exchanges — BME, XETRA, Euronext, Borsa Italiana — including microcaps and illiquid names that other tools miss.
Decision-oriented output
Results are a dense, sortable table built for action. Sort by any column, add to watchlist, open the quote — the workflow is built around making a decision, not just reading data.
Free core screener
The core screener is free with no account required. Test the filter depth and European coverage before upgrading to Pro at €29/month.
What to look for in a StockAnalysis alternative
Filter-driven screening
Can you combine multiple fundamental filters simultaneously — P/E, ROE, EV/EBITDA, margins, dividend yield — and get a ranked list of matching stocks?
European fundamental data
Does the tool cover European exchanges with populated P/E, ROE, and balance sheet data — not just US names? Are small caps and microcaps included?
Dense table output
Results should be a sortable table with dozens of columns you can scan in seconds — not a list of individual stock pages you have to click through one by one.
Heatmap
A visual heatmap of the market by sector and cap size lets you spot opportunities and rotations at a glance, without filtering first.
Free entry point
A free core screener lets you test the actual coverage and filter depth before committing to a subscription.
The 5 best StockAnalysis alternatives for filter-driven screening (2026)
ScreenerHero
Filter-driven screening across US, Canada, and all of Europe. Free core screener.
ScreenerHero is what filter-driven screening looks like. Combine 40+ fundamental and technical filters across thousands of stocks simultaneously — US, Canadian, and all European equities including microcaps. Results come back as a dense, sortable table you can act on in seconds. The core screener is free with no account required. Pro at €29/month unlocks more filters, alerts, and watchlists.
Markets
US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, built around the screener
Heatmap
Yes
Finviz
The benchmark for dense US screening — no meaningful European coverage
Finviz is the reference standard for dense, fast filter-driven screening. The free tier is genuinely useful; Elite at $39.50/month adds real-time data and saved screens. Coverage is US-only — European exchanges are not part of the product. If you screen US equities and want maximum UI density, Finviz is hard to beat. For European coverage, look elsewhere.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US equities only
UI style
Desktop-first, data-dense, screener-first
Heatmap
Yes
TIKR
Broad global coverage, loyal user base — filter depth is limited on lower tiers
TIKR has broad global reach and a loyal base of value investors. Filter-driven screening is available but the interface is less dense than Finviz or ScreenerHero. European microcap and illiquid stock coverage has known gaps. TIKR Plus starts at $10–15/month; Pro runs $40–55/month for deeper historical data and transcripts.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical financials, transcripts on Pro
UI style
Data-focused, less dense UI
Heatmap
No
Koyfin
Professional charting and dashboards — screener is secondary
Koyfin Plus is a polished charting and dashboard platform at $39/month. The screener exists but is not the primary product — if filtering thousands of stocks simultaneously is your main workflow, you are paying for charting infrastructure you may rarely use. European microcap coverage has gaps at the fundamentals level.
Markets
US + global (large and mid cap focus)
Screener filters
Fundamentals, macroeconomic overlays
UI style
Dashboard-first, chart-oriented
Heatmap
No
MarketScreener
Deep European data, news-first — screener is secondary
MarketScreener has the broadest European fundamental database of any tool reviewed here. The product is built around analyst consensus and news — screening is bolted on and the interface is dated and slow. Useful as a data source; less useful as a decision-oriented screening tool. Cheaper than StockAnalysis Premium at $30–34/month.
Markets
Europe and global
Screener filters
300–600 filters including analyst estimates
UI style
Table-based, slow, built around analyst reports
Heatmap
No
Quick comparison
| ScreenerHero | StockAnalysis | Finviz | TIKR | Koyfin | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Filter-driven screener | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Price/mo (from) | €29 | Free | $39.50 | $10 | $39 |
Recommendation by use case
You want to filter thousands of stocks simultaneously across US and European markets
ScreenerHero — free core screener, 40+ filters, dense table output, full EU microcap coverage. Pro at €29/month.
You primarily browse individual company financials and earnings history
StockAnalysis — the free tier is genuinely excellent for this workflow. Accept the lack of filter-driven screening.
You screen US stocks only and want maximum filter density
Finviz — the benchmark for US screening, at $39.50/month for the Elite tier.
You want broad global coverage at the lowest price
TIKR Plus — $10–15/month, wide reach, accept the less dense UI and European microcap gaps.
You need charting alongside occasional screening
Koyfin — $39/month, excellent charting, accept that screening is a secondary feature.
Filter thousands of stocks. Not one at a time.
Dense tables. Fast filters. Heatmap. US, Canadian, and European equities — including microcaps — in one screening-first tool. Free, no account needed. Pro at €29/month.